Trueblood Wealth Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$893K Buy
4,243
+5
+0.1% +$1.07K 0.31% 106
2026
Q1
$937K Sell
4,238
-94
-2% -$23K 0.37% 88
2025
Q4
$1.1M Sell
4,332
-103
-2% -$25.9K 0.43% 74
2025
Q3
$1.1M Sell
4,435
-21
-0.5% -$5.03K 0.43% 81
2025
Q2
$1.07M Sell
4,456
-12
-0.3% -$2.79K 0.45% 74
2025
Q1
$1.01M Sell
4,468
-55
-1% -$12.1K 0.47% 74
2024
Q4
$930K Sell
4,523
-303
-6% -$66.5K 0.46% 69
2024
Q3
$1.17M Sell
4,826
-13
-0.3% -$3.04K 0.59% 49
2024
Q2
$1.06M Sell
4,839
-14
-0.3% -$3.04K 0.6% 50
2024
Q1
$1.09M Sell
4,853
-167
-3% -$37.7K 0.62% 45
2023
Q4
$1.1M Buy
+5,020
New +$1.06M 0.69% 40

Other funds holding STE

Trueblood Wealth Management's STE Position: Q2 2026 in Review

Trueblood Wealth Management increased its Steris (STE) stake by 0.12% in Q2 2026, buying an estimated $1.07K and bringing the position to 4,243 shares worth $893K. The position accounts for 0.31% of the portfolio, ranked #106.

Trueblood Wealth Management first reported a position in STE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.17M in Q3 2024. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Trueblood Wealth Management held 4,243 shares of Steris worth $893K as of Q2 2026.
  • Trueblood Wealth Management bought 5 Steris shares in Q2 2026, an estimated $1.07K.
  • Steris made up 0.31% of Trueblood Wealth Management's portfolio in Q2 2026, its #106 holding.
  • Trueblood Wealth Management first reported a position in Steris in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's Steris position peaked at $1.17M in Q3 2024.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.